S
S

Sanofi

財經新聞

Sanofi forecasts moderate profit growth on Dupixent demand

UPDATE 2-Sanofi forecasts moderate profit growth on Dupixent demand Adds CFO comment, background By Ludwig Burger Feb 3 (Reuters) - Sanofi SASY.PA on Friday forecast moderate earnings growth this year, saying higher demand for bestselling asthma and eczema drug Dupixent would be partly offset by competition for its multiple sclerosis pill Aubagio and product launch costs.
A
R
S

Sanofi Sees 2023 Low Single Digit Business Adjusted Growth

BRIEF-Sanofi Sees 2023 Low Single Digit Business EPS FX-Adjusted Growth Feb 3 (Reuters) - Sanofi SA SASY.PA : Q4 NET SALES EUR 10.73 BILLION VERSUS EUR 10.96 BILLION IN COMPANY-PROVIDED CONSENSUS END-2022 FREE CASH FLOW FLOW INCREASED 4.8% TO EUR 8,483 MILLION Q4 BUSINESS NET INCOME EUR 2.14 BILLION VERSUS EUR 2.13 BILLION IN COMPANY-PROVIDED CONSE
S

Sanofi forecasts adjusted profit growth on Dupixent prescriptions

Sanofi forecasts FX-adjusted profit growth on Dupixent prescriptions Feb 3 (Reuters) - French drugmaker Sanofi SASY.PA forecast moderate earnings growth this year on Friday, as sustained surge in demand for its bestselling drug Dupixent would be partly offset by generic competition for established multiple sclerosis pill Aubagio. The Paris-headquartered company said it expected 2023 adjusted earnings per share to grow by a "low single digit" percentage, not taking into account an expected negati
S

Travel and leisure outlook brightens

LIVE MARKETS-Travel and leisure outlook brightens STOXX 600 down 0.6% ECB, BoE, Fed meetings this week in focus UniCredit rallies after record profit IMF cuts UK growth forecast U.S. stock futures inch lower Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com TRAVEL AND LEISURE OUTLOOK BRIGHTENS (1324 GMT) Europe's travel and leisure index .SXTP is trading near a one year high despit
A
H
P
S
S
U
E
F
U
G

Share buybacks in Europe as significant as in U.S.

LIVE MARKETS-Share buybacks in Europe as significant as in U.S. STOXX 600 down around 1% ECB, BoE, Fed meetings this week in focus UniCredit rallies after record profit IMF cuts UK growth forecast U.S. stock futures inch lower Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com SHARE BUYBACKS IN EUROPE AS SIGNIFICANT AS IN U.S.
A
P
S
S
U
E
F
U
G

細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

我們運用 cookies 提供您最佳之網頁使用經驗。更改您的cookie 設定跟詳情。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明